Prostate Cancer – Diagnosis, Treatment & Immunotherapy Advancements at RCERT

Prostate cancer is one of the most common cancers among men worldwide. It typically develops in the prostate gland, a small organ located below the bladder that plays a role in the male reproductive system. While early-stage prostate cancer may grow slowly and remain confined to the prostate, advanced stages can spread aggressively to bones and other organs.

At RCERT (Regional Cell Research & Therapy Centre), we are focused on advancing safe, personalized treatment approaches for prostate cancer — particularly through the use of cell therapy, immunotherapy, and regenerative medicine to improve patient outcomes and quality of life.

🧠 What Is Prostate Cancer?

Prostate cancer begins when cells in the prostate gland grow uncontrollably. Most prostate cancers are adenocarcinomas, which develop from glandular tissue.

While many cases are slow-growing and may not cause immediate harm, some types are aggressive and require prompt medical intervention.

📊 Prostate Cancer in Malaysia and Southeast Asia

• Among the top five cancers affecting men in Malaysia.

• Risk increases significantly after age 50.

• Lifestyle, diet, genetics, and ethnicity are known contributing factors.

• Earlier detection through screening is improving outcomes, but late-stage diagnosis remains common in the region.

🩺 Common Symptoms of Prostate Cancer

In the early stages, prostate cancer often has no symptoms. When they do appear, they may include:

• Difficulty or pain during urination

• Weak or interrupted urine flow

• Frequent urination (especially at night)

• Blood in urine or semen

• Pain in the back, hips, or pelvis

• Erectile dysfunction

These symptoms may also be caused by non-cancerous prostate conditions like benign prostatic hyperplasia (BPH), so proper screening is essential.

🧪 Diagnosis & Screening

RCERT supports early detection strategies as a vital part of preventive healthcare. Common diagnostic tools include:

• PSA (Prostate-Specific Antigen) Blood Test: Measures PSA levels; elevated levels may indicate prostate abnormalities.

• Digital Rectal Exam (DRE): A manual exam to feel for lumps or abnormalities.

• Prostate Biopsy: Confirms cancer by extracting tissue for pathology.

• MRI and Bone Scans: Evaluate the extent of disease, especially if metastasis is suspected.

RCERT’s advanced lab diagnostics and personalized patient consultations help ensure accurate diagnosis and timely decision-making.

🧬 Prostate Cancer Treatment Options

The choice of treatment depends on the stage, grade (Gleason score), PSA level, overall health, and patient preferences. Options include:

1. Active Surveillance

• For slow-growing cancer with low PSA.

• Regular monitoring without immediate treatment.

2. Surgery

• Radical prostatectomy (removal of the prostate).

• Suitable for localized prostate cancer.

3. Radiation Therapy

• External beam radiation or brachytherapy.

• Can be used alone or after surgery.

4. Hormone Therapy (ADT)

• Reduces levels of male hormones (androgens) that fuel cancer growth.

5. Chemotherapy

• Typically used in metastatic or hormone-resistant prostate cancer.

6. Immunotherapy and Cell Therapy

At RCERT, we offer personalized cellular therapy approaches, including:

• DC (Dendritic Cell) Therapy

• DC-CTL Therapy – trains T-cells to recognize and destroy cancer

• CIK and DC-CIK Therapy

• NK Cell Therapy – targets resistant or recurrent prostate cancer

• Exosome-supported immune modulation

These advanced treatments help stimulate the immune system to fight cancer naturally, with lower toxicity than traditional options.

🌟 RCERT’s Innovative Approach to Prostate Cancer

RCERT combines clinical experience with advanced technology to offer a multidisciplinary, patient-centered approach. Our prostate cancer care model includes:

• Early screening and risk profiling

• Personalized treatment planning

• Integration of conventional and advanced therapies

• Cell therapy-based immunotherapy programs

• Supportive anti-aging and regenerative protocols

• Patient monitoring and quality-of-life enhancement

Our Cell Processing Laboratory and Cell Therapy Clinical Centre operate under GMP and clinical safety standards, ensuring world-class care.

🧬 Immunotherapy for Prostate Cancer: How It Works

Immunotherapy trains the patient’s immune system to recognize and attack prostate cancer cells.

At RCERT, we use dendritic cells (DC) loaded with prostate cancer-specific antigens (e.g., PSA, PAP) to activate T cells (CTLs), which then seek and destroy tumor cells. In some cases, we combine this with CIK or NK cell therapy to improve immune response.

These therapies are especially valuable for:

• Patients who do not respond well to hormone or chemotherapy

• Those with metastatic or relapsed cancer

• Individuals who want non-toxic, immune-boosting alternatives

💬 Why Choose RCERT for Prostate Cancer Care?

• ✅ Personalized cell therapy designed to your immune profile

• ✅ Collaboration with UNIMAS and Zhongrong Cell Technology Center (China)

• ✅ GMP-certified lab and clinical-grade protocols

• ✅ Integrated cancer care with anti-aging and wellness support

• ✅ Compassionate, professional team of researchers and physicians

👤 Who Is Eligible for Cell-Based Therapy?

You may be eligible if you:

• Are diagnosed with early, locally advanced, or metastatic prostate cancer

• Have completed standard therapy and want immune support

• Seek alternative/complementary therapies

• Are open to participating in investigational or advanced treatment protocols

RCERT offers a comprehensive medical evaluation before treatment is recommended.

⚠️ Side Effects & Recovery

While conventional treatments may cause fatigue, urinary issues, and sexual dysfunction, cell therapy is generally well-tolerated. Most patients report:

• Improved energy

• Enhanced immune function

• Reduced inflammatory markers

• No hair loss or nausea

• Minimal systemic side effects

Our team monitors each patient carefully to ensure safety and optimal response.

📈 Research and Future Directions

RCERT is actively involved in prostate cancer research, including:

• Clinical trials for DC-CTL and DC-CIK therapy

• Development of DNA methylation-based risk tests

• Exosome-supported immune repair

• Immuno-nutrition and wellness programs for prostate support

We are working to combine diagnostics, prevention, and therapy in a seamless, patient-friendly care experience.

📞 Contact Us

If you or a loved one is facing prostate cancer and are interested in cell-based or personalized immunotherapy:

📍 RCERT – Cell Therapy Clinical Centre
UNIMAS, Sarawak & Kota Damansara, Selangor, Malaysia

📝 Conclusion

Prostate cancer is a serious but treatable disease — especially when caught early and approached with a personalized treatment plan. At RCERT, we bring together science, care, and innovation to provide better outcomes and longer, healthier lives for men with prostate cancer.

Let us help you explore advanced, targeted solutions through cell therapy and immunotherapy.

📆 Book your consultation today.